Retec Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.75 M
- Company Age 27 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.33 Cr
- Revenue Growth %
- Profit Growth 32.03%
- Ebitda -23.08%
- Net Worth -80.85%
- Total Assets -10.53%
About Retec Formulations
Retec Formulations Private Limited (RFPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 February 1998 and has a history of 27 years. Its registered office is in New Delhil, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹1.33 Cr.
Suvidha Pandey and Anjani Pandey serve as directors at the Company.
Company Details
-
Location
New Delhil, Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33110DL1998PTC092158
-
Company No.
092158
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Feb 1998
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Retec Formulations Private Limited offer?
Retec Formulations Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Multivitamin Syrup & Drops, Antioxidant Syrup, Mineral Supplement, Calcium Tablet, Calcium Syrup, Calcium & Vitamin D3 Tablet, Protein Powder, Chocolate Protein Powder, Nutritional Supplements.
Who are the key members and board of directors at Retec Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suvidha Pandey
|
Director | 09-Feb-1998 | Current |
|
Anjani Pandey
|
Director | 09-Feb-1998 | Current |
Financial Performance of Retec Formulations.
Retec Formulations Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 32.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 80.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Retec Formulations?
In 2022, Retec Formulations had a promoter holding of 93.33% and a public holding of 6.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Retec Healthcare Private LimitedSuvidha Pandey and Anjani Pandey are mutual person
Charges (Loans)
₹13.30 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.20 Cr
- Oriental Bank Of Commerce : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 May 2013 | Oriental Bank Of Commerce | ₹1.10 M | Open |
| 01 Mar 2006 | Others | ₹1.20 Cr | Open |
| 16 Jun 1999 | Oriental Bank Of Commerce | ₹0.20 M | Open |
How Many Employees Work at Retec Formulations?
Unlock and access historical data on people associated with Retec Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Retec Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Retec Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
